Difference between revisions of "Hepatocyte nuclear factor-1beta"

From Libre Pathology
Jump to navigation Jump to search
(create)
 
(more)
Line 4: Line 4:
*[[Clear cell carcinoma of the ovary]].
*[[Clear cell carcinoma of the ovary]].
*[[Clear cell renal cell carcinoma]].<ref name=pmid26574638>{{cite journal |vauthors=Hanley KZ, Cohen C, Osunkoya AO |title=Hepatocyte Nuclear Factor-1β Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall |journal=Appl. Immunohistochem. Mol. Morphol. |volume=25 |issue=2 |pages=134–138 |date=February 2017 |pmid=26574638 |doi=10.1097/PAI.0000000000000279 |url=}}</ref>
*[[Clear cell renal cell carcinoma]].<ref name=pmid26574638>{{cite journal |vauthors=Hanley KZ, Cohen C, Osunkoya AO |title=Hepatocyte Nuclear Factor-1β Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall |journal=Appl. Immunohistochem. Mol. Morphol. |volume=25 |issue=2 |pages=134–138 |date=February 2017 |pmid=26574638 |doi=10.1097/PAI.0000000000000279 |url=}}</ref>
==Negative==
*[[Serous carcinoma of the ovary]].


==References==
==References==

Revision as of 21:27, 2 July 2020

HNF-1beta, also HNF-1β, in an immunostain that marks clear cell carcinoma of the ovary.

Positive

Negative

References

  1. "Hepatocyte Nuclear Factor-1β Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall". Appl. Immunohistochem. Mol. Morphol. 25 (2): 134–138. February 2017. doi:10.1097/PAI.0000000000000279. PMID 26574638.